美国 · 财经报刊 · Investor's Business Daily
Arcus Dips, But Recovers From Steep Losses, On Merck-Rivaling Cancer Data
Arcus Biosciences touted its Merck-rivaling kidney cancer treatment results Tuesday, but shares took a swim. The post Arcus Dips, But Recovers From Steep Losses, On Merck-Rivaling…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
